News

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...
Lower blood sugar and increased fat burning—without negatively affecting appetite or muscle mass. These are some of the most ...
People who received higher doses of amycretin as a weekly injection lost 24.3 per cent of their body weight after 36 weeks of ...
Oisín's groundbreaking therapies—focused on targeted fat reduction, muscle regeneration, and cellular senescence—have garnered significant interest from leading pharmaceutical companies and ...
SEATTLE, December 18, 2024--Oisín Biotechnologies, a leading genetic medicines company developing therapies for age-related diseases, announced today that it has been awarded a grant from ...
A FAMOUS tech millionaire who has picked up a fight against body ageing now looks unrecognisable after taking controversial fat injections. Biohacker Bryan Johnson, 47, revealed shocking … ...
Caliway Biopharmaceuticals (Caliway) completed CBL-514 Phase 2b study for non-surgical fat reduction (CBL-0205, clinicaltrials.gov ID: NCT06005441) on October 22nd, 2024, with the topline results ...
Vivani’s GLP-1 (exenatide) implant produced sham-implant adjusted liver fat reduction of 82% in an obese mouse model from a single administration with expected twice-yearly dosing Vivani ...
DENVER — A Louisville, Colorado, company is studying whether cells taken from patients’ fat could reduce knee pain and improve motion in people with arthritis.
A Louisville, Colorado, company is studying whether cells taken from patients' fat could reduce knee pain and improve motion in people with arthritis. GID BIO is conducting a Phase III trial of a ...